Related Experiment Video
Updated: Jul 31, 2026

Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment
Published on: September 27, 2017
No effects of probiotics on atopic dermatitis in infancy: a randomized placebo-controlled trial
M L Brouwer1, S A A Wolt-Plompen, A E J Dubois
1Department of Paediatrics, Division of Paediatric Pulmonology, University Medical Center Groningen, Beatrix Children's Hospital, Groningen, The Netherlands. m.l.brouwer@bkk.umbg
Insights
Probiotic supplementation did not significantly improve atopic dermatitis (AD) symptoms or immunological markers in infants. This study found no clinical benefit of using these specific probiotic strains for infantile AD.
Area of Science:
- Immunology
- Pediatrics
- Microbiology
Background:
- Probiotics are investigated for potential benefits in preventing and treating allergic diseases, especially in infants with atopic dermatitis (AD).
- Previous studies suggest a possible therapeutic role for probiotics in managing sensitization and atopic conditions.
Purpose of the Study:
- To assess the clinical and immunological impact of supplementing a hydrolyzed formula with two specific probiotic strains.
- To evaluate the effects on the symptoms of atopic dermatitis in infants.
Main Methods:
- A randomized, double-blind, placebo-controlled trial involving infants under 5 months with AD.
- Infants received a hydrolyzed whey formula with either Lactobacillus rhamnosus, Lactobacillus GG, or placebo for 3 months.
- Clinical severity (SCORAD), allergic sensitization (IgE levels, skin prick tests), and inflammatory markers were assessed.
Main Results:
- No statistically significant differences were observed in SCORAD, sensitization, or inflammatory parameters between the probiotic and placebo groups.
- Cytokine production (IL-4, IL-5, IFN-gamma) also showed no significant changes.
- Cow's milk allergy (CMA) was diagnosed in only four infants.
Conclusions:
- The studied probiotic bacteria demonstrated no significant clinical or immunological effects in infants with atopic dermatitis.
- Oral supplementation with these specific probiotic strains is unlikely to substantially impact infantile AD symptoms.
Background:
Studies have been performed suggesting that administration of probiotics may have therapeutic and/or preventive benefits in the development of sensitization and atopic disease, particularly in infants with atopic dermatitis (AD).
Objective:
The purpose of this study was to evaluate the clinical and immunological effects of supplementation of a hydrolysed formula with two probiotic strains of bacteria on symptoms of AD in infancy.
Methods:
We conducted a randomized, double-blind, placebo-controlled study. After 4-6 weeks of baseline and double-blind, placebo-controlled challenges for diagnosis of cow's milk allergy (CMA), infants less than 5 months old with AD received a hydrolysed whey-based formula as placebo (n = 17), or supplemented with either Lactobacillus rhamnosus (n = 17) or Lactobacillus GG (n = 16) for 3 months. Before, during and after intervention, the clinical severity of AD was evaluated using SCORing index Atopic Dermatitis (SCORAD). Allergic sensitization was evaluated by measurement of total IgE and a panel of food-specific IgEs as well as skin prick testing for cow's milk. Inflammatory parameters were blood eosinophils, eosinophil protein X in urine, fecal alpha-1-antitrypsin and production of IL-4, IL-5 and IFN-gamma by peripheral blood mononuclear cells after polyclonal stimulation.
Results:
No statistically significant effects of probiotic supplementation on SCORAD, sensitization, inflammatory parameters or cytokine production between groups were found. Only four infants were diagnosed with CMA.
Conclusion:
We found no clinical or immunological effect of the probiotic bacteria used in infants with AD. Our results indicate that oral supplementation with these probiotic bacterial strains will not have a significant impact on the symptoms of infantile AD.
Related Concept Videos
Development of Human Microbiota
Microbiota Modulation by Antibiotics
Acne Infection

